Marksans Pharma up 5% on settlement with FCCBs' holders

Marksans Pharma rallied 5 percent on Monday as the company entered into a settlement agreement with the holders of foreign currency convertible bonds (FCCBs) for settling USD 26,918,000 worth of FCCBs in principal value.

March 04, 2013 / 14:21 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Marksans Pharma rallied 5 percent on Monday as the company entered into a settlement agreement with the holders of foreign currency convertible bonds (FCCBs) for settling USD 26,918,000 worth of FCCBs in principal value.

At 14:14 hours IST, shares were quoting at Rs 3.99 amid high volumes on Bombay Stock Exchange.

There were pending buy orders of 22,709 shares, with no sellers available.

Trading volumes increased 47 percent to 6,23,421 equity shares as against five-day average of 4,22,193 shares.

Market capitalisation of the company currently stands at Rs 153.74 crore.

first published: Mar 4, 2013 02:21 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347